AAAAAA
Results:
1-7
|
Results: 7
Authors:
Striggow, F
Riek-Burchardt, M
Kiesel, A
Schmidt, W
Henrich-Noack, P
Breder, J
Krug, M
Reymann, KG
Reiser, G
Citation: F. Striggow et al., Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia, EUR J NEURO, 14(4), 2001, pp. 595-608
Authors:
Henrich-Noack, P
Flor, PJ
Sabelhaus, CF
Prass, K
Dirnagl, U
Gasparini, F
Sauter, A
Rudin, M
Reymann, KG
Citation: P. Henrich-noack et al., Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronaldamage, NEUROPHARM, 39(5), 2000, pp. 911-917
Authors:
Striggow, F
Riek, M
Breder, J
Henrich-Noack, P
Reymann, KG
Reiser, G
Citation: F. Striggow et al., The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at highconcentrations, P NAS US, 97(5), 2000, pp. 2264-2269
Authors:
Sabelhaus, CF
Schroder, UH
Breder, J
Henrich-Noack, P
Reymann, KG
Citation: Cf. Sabelhaus et al., Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine, BR J PHARM, 131(4), 2000, pp. 655-658
Authors:
Rauca, C
Henrich-Noack, P
Schafer, K
Hollt, V
Reymann, KG
Citation: C. Rauca et al., (S)-4C3HPG reduces infarct size after focal cerebral ischemia (vol 37, pg 1649, 1998), NEUROPHARM, 38(2), 1999, pp. 327-327
Authors:
Henrich-Noack, P
Reymann, KG
Citation: P. Henrich-noack et Kg. Reymann, (1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia, EUR J PHARM, 365(1), 1999, pp. 55-58
Authors:
Rauca, C
Henrich-Noack, P
Schafer, K
Hollt, V
Reymann, KG
Citation: C. Rauca et al., (S)-4C3HPG reduces infarct size after focal cerebral ischemia, NEUROPHARM, 37(12), 1998, pp. 1649-1652
Risultati:
1-7
|